Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Pharmaceutical Research and Manufacturers of America
Pharmaceutical Research and Manufacturers of America
Activities:
Media
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Life sciences sector hit with funding cuts, but novel report highlights feasible industry solutions
The review highlights the recent investment reductions observed within the life sciences industry, and why its important to support smaller businesses to develop their innovations
Enhancing sterility: the crucial role of isolators in sterile fill-finish
Maintaining the highest levels of sterility is paramount to ensure the safety and efficacy of drugs, with good aseptic manufacturing practices playing a pivotal role in...
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Teva & Medincell release Phase III SOLARIS trial results for olanzapine in schizophrenic adults
The results indicate that Medincell's TEV-'749 subcutaneous extended release device for the administration of olanzapine in schizophrenic adults met primary and secondary...
DevPro Biopharma and Bespak complete early studies for novel sustainable albuterol inhaler
The novel formulation exhibits a low global warming potential (GWP) and shows comparable performance to Ventolin HFA
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Regulatory
PhRMA board talk with President Trump
PhRMA CEO has issued a statement following his meeting with President Trump regarding the US biopharmaceutical industry
Research & Development
PhRMA member companies invested US$58.8bn in R&D in 2015
Biopharmaceutical industry continues to be most R&D-intensive industry in US economy
You need to be a subscriber to read this article.
Click here
to find out more.
Finance
TPP agreement – a bitter pill to swallow?
US negotiatiors have had to make concessions over biologics protection to secure a Trans-Pacific Partnership (TPP) deal, but health campaigners are unimpressed
Research & Development
PhRMA reports 836 medicines and vaccines in development to treat cancer
Building on decades of progress in the fight against the disease, a robust pipeline of potential new treatments sustains hope for patients and their families
Regulatory
US pharma associations clash over Trans-Pacific Partnership (TPP)
After President Obama secures trade promotion authority powers
Regulatory
Sanofi to expand access to clinical trial data
In support of PhRMA and EFPIA principles on responsible sharing of data
Finance
PhRMA sounds alarm over US budget cuts
Criticises proposal on generics
Subscribe now